Thus, we concluded that ITGB2 signal pathway (PI3K-AKT-mTOR) could enhance mitochondrial glycolysis in ovarian cancer cells through upregulating rate-limiting enzymes. The gene discussed is AKT1; the disease is ovarian carcinoma.